Timing of infliximab and adalimumab initiation despite methotrexate in children with chronic non-infectious anterior uveitis

AIMS: Methotrexate (MTX) is standard treatment in pediatric chronic anterior uveitis (CAU). Addition of tumor necrosis factor-α inhibitors (TNFi) is often needed. We describe the timing and risk factors for TNFi use in children with CAU on MTX. METHODS: In this retrospective study, we reviewed 51 re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eye (Lond)
Main Authors: McCracken, Courtney, Yeh, Steven, Jenkins, Kirsten, Travers, Curtis, Stryker, Daneka, Tommasello, Steven, Rouster-Stevens, Kelly A., Lambert, Scott R., Prahalad, Sampath, Drews-Botsch, Carolyn, Angeles-Han, Sheila T.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6461976/
https://ncbi.nlm.nih.gov/pubmed/30487588
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41433-018-0283-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados